Literature DB >> 32568408

Virus harvesting in perfusion culture: Choosing the right type of hollow fiber membrane.

Alexander Nikolay1, Joris de Grooth2, Yvonne Genzel1, Jeffery A Wood3, Udo Reichl1,4.   

Abstract

The use of bioreactors coupled to membrane-based perfusion systems enables very high cell and product concentrations in vaccine and viral vector manufacturing. Many virus particles, however, are not stable and either lose their infectivity or physically degrade resulting in significant product losses if not harvested continuously. Even hollow fiber membranes with a nominal pore size of 0.2 µm can retain much smaller virions within a bioreactor. Here, we report on a systematic study to characterize structural and physicochemical membrane properties with respect to filter fouling and harvesting of yellow fever virus (YFV; ~50 nm). In tangential flow filtration perfusion experiments, we observed that YFV retention was only marginally determined by nominal but by effective pore sizes depending on filter fouling. Evaluation of scanning electron microscope images indicated that filter fouling can be reduced significantly by choosing membranes with (i) a flat inner surface (low boundary layer thickness), (ii) a smooth material structure (reduced deposition), (iii) a high porosity (high transmembrane flux), (iv) a distinct pore size distribution (well-defined pore selectivity), and (v) an increased fiber wall thickness (larger effective surface area). Lowest filter fouling was observed with polysulfone (PS) membranes. While the use of a small-pore PS membrane (0.08 µm) allowed to fully retain YFV within the bioreactor, continuous product harvesting was achieved with the large-pore PS membrane (0.34 µm). Due to the low protein rejection of the latter, this membrane type could also be of interest for other applications, that is, recombinant protein production in perfusion cultures.
© 2020 The Authors. Biotechnology and Bioengineering published by Wiley Periodicals LLC.

Entities:  

Keywords:  SEM; cell culture-based virus production; hollow fiber membrane; perfusion

Year:  2020        PMID: 32568408     DOI: 10.1002/bit.27470

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  4 in total

1.  Intensifying Continuous Production of Gag-HA VLPs at High Cell Density Using Stable Insect Cells Adapted to Low Culture Temperature.

Authors:  Bárbara Fernandes; Ricardo Correia; Paula M Alves; António Roldão
Journal:  Front Bioeng Biotechnol       Date:  2022-06-29

2.  Cell culture-based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system.

Authors:  Marc D Hein; Anshika Chawla; Maurizio Cattaneo; Sascha Y Kupke; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2021-09-14       Impact factor: 4.813

3.  The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process.

Authors:  Jianqi Nie; Yang Sun; Kai Feng; Lingling Huang; Ye Li; Zhonghu Bai
Journal:  Vaccine       Date:  2022-02-23       Impact factor: 4.169

Review 4.  Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects.

Authors:  Zhongbiao Fang; Jingting Lyu; Jianhua Li; Chaonan Li; Yuxuan Zhang; Yikai Guo; Ying Wang; Yanjun Zhang; Keda Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.